U.S. markets open in 2 hours 12 minutes
  • S&P Futures

    4,173.25
    +19.75 (+0.48%)
     
  • Dow Futures

    33,360.00
    +205.00 (+0.62%)
     
  • Nasdaq Futures

    14,102.00
    +67.00 (+0.48%)
     
  • Russell 2000 Futures

    2,244.10
    +13.50 (+0.61%)
     
  • Crude Oil

    71.85
    +0.21 (+0.29%)
     
  • Gold

    1,782.70
    +13.70 (+0.77%)
     
  • Silver

    26.05
    +0.08 (+0.31%)
     
  • EUR/USD

    1.1896
    +0.0031 (+0.26%)
     
  • 10-Yr Bond

    1.4500
    0.0000 (0.00%)
     
  • Vix

    20.14
    +2.39 (+13.46%)
     
  • GBP/USD

    1.3879
    +0.0070 (+0.51%)
     
  • USD/JPY

    110.1100
    -0.0400 (-0.04%)
     
  • BTC-USD

    32,304.96
    -1,853.20 (-5.43%)
     
  • CMC Crypto 200

    787.79
    -152.16 (-16.19%)
     
  • FTSE 100

    7,024.88
    +7.41 (+0.11%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

Syndax Lower as Blood Cancer Drug Trial Disappoints Investors

·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

The results of Syndax's Phase 1 trial of a blood-cancer-treatment candidate came up short of an investment firm's estimate.